首页 > 最新文献

The Lancet最新文献

英文 中文
A just transition for antimicrobial resistance: planning for an equitable and sustainable future with antimicrobial resistance. 抗菌药耐药性的公正过渡:规划抗菌药耐药性的公平和可持续未来。
IF 98.4 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-06-29 Epub Date: 2023-09-08 DOI: 10.1016/S0140-6736(23)01687-2
{"title":"A just transition for antimicrobial resistance: planning for an equitable and sustainable future with antimicrobial resistance.","authors":"","doi":"10.1016/S0140-6736(23)01687-2","DOIUrl":"10.1016/S0140-6736(23)01687-2","url":null,"abstract":"","PeriodicalId":18014,"journal":{"name":"The Lancet","volume":" ","pages":"2766-2767"},"PeriodicalIF":98.4,"publicationDate":"2024-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10215489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The future of engaging patients and families for patient safety. 让患者和家属参与患者安全的未来。
IF 98.4 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-03-02 Epub Date: 2023-09-15 DOI: 10.1016/S0140-6736(23)01908-6
Jane K O'Hara, Carolyn Canfield
{"title":"The future of engaging patients and families for patient safety.","authors":"Jane K O'Hara, Carolyn Canfield","doi":"10.1016/S0140-6736(23)01908-6","DOIUrl":"10.1016/S0140-6736(23)01908-6","url":null,"abstract":"","PeriodicalId":18014,"journal":{"name":"The Lancet","volume":" ","pages":"791-793"},"PeriodicalIF":98.4,"publicationDate":"2024-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10361533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Towards an equitable people-centred health system for Spain. 为西班牙建立以人为本的公平医疗体系。
IF 98.4 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-01-27 Epub Date: 2023-09-06 DOI: 10.1016/S0140-6736(23)01858-5
Helena Legido-Quigley, Itxaso Berrojalbiz, Manuel Franco, Montserrat Gea-Sánchez, Sara Jaurrieta, Muriel Larrea, Sergio Minue, Javier Padilla, Jose Maria Valderas, Tomas Zapata
{"title":"Towards an equitable people-centred health system for Spain.","authors":"Helena Legido-Quigley, Itxaso Berrojalbiz, Manuel Franco, Montserrat Gea-Sánchez, Sara Jaurrieta, Muriel Larrea, Sergio Minue, Javier Padilla, Jose Maria Valderas, Tomas Zapata","doi":"10.1016/S0140-6736(23)01858-5","DOIUrl":"10.1016/S0140-6736(23)01858-5","url":null,"abstract":"","PeriodicalId":18014,"journal":{"name":"The Lancet","volume":" ","pages":"335-337"},"PeriodicalIF":98.4,"publicationDate":"2024-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10557457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transferable exclusivity voucher: a flawed incentive to stimulate antibiotic innovation. 可转让专有权凭证:激励抗生素创新的错误激励机制。
IF 98.4 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-01-13 Epub Date: 2023-02-09 DOI: 10.1016/S0140-6736(23)00282-9
Christine Årdal, Enrico Baraldi, Reinhard Busse, Rosa Castro, Francesco Ciabuschi, José Miguel Cisneros, Inge C Gyssens, Stephan Harbarth, Tomislav Kostyanev, Yohann Lacotte, Nicola Magrini, Anthony McDonnell, Annelie A Monnier, Suerie Moon, Elias Mossialos, Germán Peñalva, Marie-Cécile Ploy, Momir Radulović, Adrián Alonso Ruiz, John-Arne Røttingen, Michael Sharland, Evelina Tacconelli, Ursula Theuretzbacher, Sabine Vogler, Ute Wolff Sönksen, Kerstin Åkerfeldt, Otto Cars, Jim O'Neill
{"title":"Transferable exclusivity voucher: a flawed incentive to stimulate antibiotic innovation.","authors":"Christine Årdal, Enrico Baraldi, Reinhard Busse, Rosa Castro, Francesco Ciabuschi, José Miguel Cisneros, Inge C Gyssens, Stephan Harbarth, Tomislav Kostyanev, Yohann Lacotte, Nicola Magrini, Anthony McDonnell, Annelie A Monnier, Suerie Moon, Elias Mossialos, Germán Peñalva, Marie-Cécile Ploy, Momir Radulović, Adrián Alonso Ruiz, John-Arne Røttingen, Michael Sharland, Evelina Tacconelli, Ursula Theuretzbacher, Sabine Vogler, Ute Wolff Sönksen, Kerstin Åkerfeldt, Otto Cars, Jim O'Neill","doi":"10.1016/S0140-6736(23)00282-9","DOIUrl":"10.1016/S0140-6736(23)00282-9","url":null,"abstract":"","PeriodicalId":18014,"journal":{"name":"The Lancet","volume":" ","pages":"e2-e4"},"PeriodicalIF":98.4,"publicationDate":"2024-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10685290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The emerging fentanyl-xylazine syndemic in the USA: challenges and future directions. 美国新出现的芬太尼-甲苯噻嗪综合征:挑战和未来方向。
IF 168.9 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-11-25 Epub Date: 2023-08-24 DOI: 10.1016/S0140-6736(23)01686-0
David T Zhu, Joseph Friedman, Philippe Bourgois, Fernando Montero, Suzanne Tamang
{"title":"The emerging fentanyl-xylazine syndemic in the USA: challenges and future directions.","authors":"David T Zhu, Joseph Friedman, Philippe Bourgois, Fernando Montero, Suzanne Tamang","doi":"10.1016/S0140-6736(23)01686-0","DOIUrl":"10.1016/S0140-6736(23)01686-0","url":null,"abstract":"","PeriodicalId":18014,"journal":{"name":"The Lancet","volume":" ","pages":"1949-1952"},"PeriodicalIF":168.9,"publicationDate":"2023-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10842070/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10439141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
El Niño and health in an era of unprecedented climate change. 在前所未有的气候变化时代,El Niño和健康。
IF 168.9 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-11-18 Epub Date: 2023-08-16 DOI: 10.1016/S0140-6736(23)01664-1
Andy Haines, Holly C Y Lam
{"title":"El Niño and health in an era of unprecedented climate change.","authors":"Andy Haines, Holly C Y Lam","doi":"10.1016/S0140-6736(23)01664-1","DOIUrl":"10.1016/S0140-6736(23)01664-1","url":null,"abstract":"","PeriodicalId":18014,"journal":{"name":"The Lancet","volume":" ","pages":"1811-1813"},"PeriodicalIF":168.9,"publicationDate":"2023-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10028027","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health can contribute to peace in the Eastern Mediterranean Region-what should be done to make it happen? 健康可以促进东地中海地区的和平,应该采取什么措施来实现这一目标?
IF 168.9 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-11-04 Epub Date: 2023-09-06 DOI: 10.1016/S0140-6736(23)01795-6
Wasiq Khan, Mohamed Jama, Arturo Pesigan, Akihiro Seita, Maha El-Adawy, Richard Brennan, Sania Nishtar
{"title":"Health can contribute to peace in the Eastern Mediterranean Region-what should be done to make it happen?","authors":"Wasiq Khan, Mohamed Jama, Arturo Pesigan, Akihiro Seita, Maha El-Adawy, Richard Brennan, Sania Nishtar","doi":"10.1016/S0140-6736(23)01795-6","DOIUrl":"10.1016/S0140-6736(23)01795-6","url":null,"abstract":"","PeriodicalId":18014,"journal":{"name":"The Lancet","volume":" ","pages":"1601-1603"},"PeriodicalIF":168.9,"publicationDate":"2023-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10188706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Transforming women's, children's, and adolescents' health and wellbeing through primary health care. 通过初级卫生保健改善妇女、儿童和青少年的健康和福祉。
IF 168.9 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-11-04 Epub Date: 2023-09-15 DOI: 10.1016/S0140-6736(23)01909-8
{"title":"Transforming women's, children's, and adolescents' health and wellbeing through primary health care.","authors":"","doi":"10.1016/S0140-6736(23)01909-8","DOIUrl":"10.1016/S0140-6736(23)01909-8","url":null,"abstract":"","PeriodicalId":18014,"journal":{"name":"The Lancet","volume":" ","pages":"1606-1608"},"PeriodicalIF":168.9,"publicationDate":"2023-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10308021","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Lancet Commission on peaceful societies through health equity and gender equality. 通过卫生公平和性别平等促进和平社会的《柳叶刀》委员会。
IF 168.9 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-11-04 Epub Date: 2023-09-06 DOI: 10.1016/S0140-6736(23)01348-X
Valerie Percival, Oskar T Thoms, Ben Oppenheim, Dane Rowlands, Carolyn Chisadza, Sara Fewer, Gavin Yamey, Amy C Alexander, Chloe L Allaham, Sara Causevic, François Daudelin, Siri Gloppen, Debarati Guha-Sapir, Maseh Hadaf, Samuel Henderson, Steven J Hoffman, Ana Langer, Toni Joe Lebbos, Luiz Leomil, Minna Lyytikäinen, Anju Malhotra, Paul Mkandawire, Holly A Norris, Ole Petter Ottersen, Jason Phillips, Sigrún Rawet, Alexa Salikova, Idil Shekh Mohamed, Ghazal Zazai, Tarja Halonen, Catherine Kyobutungi, Zulfiqar A Bhutta, Peter Friberg
{"title":"The Lancet Commission on peaceful societies through health equity and gender equality.","authors":"Valerie Percival, Oskar T Thoms, Ben Oppenheim, Dane Rowlands, Carolyn Chisadza, Sara Fewer, Gavin Yamey, Amy C Alexander, Chloe L Allaham, Sara Causevic, François Daudelin, Siri Gloppen, Debarati Guha-Sapir, Maseh Hadaf, Samuel Henderson, Steven J Hoffman, Ana Langer, Toni Joe Lebbos, Luiz Leomil, Minna Lyytikäinen, Anju Malhotra, Paul Mkandawire, Holly A Norris, Ole Petter Ottersen, Jason Phillips, Sigrún Rawet, Alexa Salikova, Idil Shekh Mohamed, Ghazal Zazai, Tarja Halonen, Catherine Kyobutungi, Zulfiqar A Bhutta, Peter Friberg","doi":"10.1016/S0140-6736(23)01348-X","DOIUrl":"10.1016/S0140-6736(23)01348-X","url":null,"abstract":"","PeriodicalId":18014,"journal":{"name":"The Lancet","volume":" ","pages":"1661-1722"},"PeriodicalIF":168.9,"publicationDate":"2023-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10188702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Effect of colchicine on perioperative atrial fibrillation and myocardial injury after non-cardiac surgery in patients undergoing major thoracic surgery (COP-AF): an international randomised trial. 秋水仙碱对大胸外科手术(COP-AF)患者围术期心房颤动和非心脏手术后心肌损伤的影响:一项国际随机试验
IF 168.9 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-11-04 Epub Date: 2023-08-25 DOI: 10.1016/S0140-6736(23)01689-6
David Conen, Michael Ke Wang, Ekaterine Popova, Matthew T V Chan, Giovanni Landoni, Juan P Cata, Cara Reimer, Sean R McLean, Sadeesh K Srinathan, Juan Carlos Trujillo Reyes, Ascension Martín Grande, Anna Gonzalez Tallada, Daniel I Sessler, Edith Fleischmann, Barbara Kabon, Luca Voltolini, Patrícia Cruz, Donna E Maziak, Laura Gutiérrez-Soriano, William F McIntyre, Vikas Tandon, Elisabeth Martínez-Téllez, Juan Jose Guerra-Londono, Deborah DuMerton, Randolph H L Wong, Anna L McGuire, Biniam Kidane, Diego Parise Roux, Yaron Shargall, Jennifer R Wells, Sandra N Ofori, Jessica Vincent, Lizhen Xu, Zhuoru Li, John W Eikelboom, Sanjit S Jolly, Jeff S Healey, P J Devereaux

Background: Higher levels of inflammatory biomarkers are associated with an increased risk of perioperative atrial fibrillation and myocardial injury after non-cardiac surgery (MINS). Colchicine is an anti-inflammatory drug that might reduce the incidence of these complications.

Methods: COP-AF was a randomised trial conducted at 45 sites in 11 countries. Patients aged 55 years or older and undergoing major non-cardiac thoracic surgery were randomly assigned (1:1) to receive oral colchicine 0·5 mg twice daily or matching placebo, starting within 4 h before surgery and continuing for 10 days. Randomisation was done with use of a computerised, web-based system, and was stratified by centre. Health-care providers, patients, data collectors, and adjudicators were masked to treatment assignment. The coprimary outcomes were clinically important perioperative atrial fibrillation and MINS during 14 days of follow-up. The main safety outcomes were a composite of sepsis or infection, and non-infectious diarrhoea. The intention-to-treat principle was used for all analyses. This trial is registered with ClinicalTrials.gov, NCT03310125.

Findings: Between Feb 14, 2018, and June 27, 2023, we enrolled 3209 patients (mean age 68 years [SD 7], 1656 [51·6%] male). Clinically important atrial fibrillation occurred in 103 (6·4%) of 1608 patients assigned to colchicine, and 120 (7·5%) of 1601 patients assigned to placebo (hazard ratio [HR] 0·85, 95% CI 0·65 to 1·10; absolute risk reduction [ARR] 1·1%, 95% CI -0·7 to 2·8; p=0·22). MINS occurred in 295 (18·3%) patients assigned to colchicine and 325 (20·3%) patients assigned to placebo (HR 0·89, 0·76 to 1·05; ARR 2·0%, -0·8 to 4·7; p=0·16). The composite outcome of sepsis or infection occurred in 103 (6·4%) patients in the colchicine group and 83 (5·2%) patients in the placebo group (HR 1·24, 0·93-1·66). Non-infectious diarrhoea was more common in the colchicine group (134 [8·3%] events) than the placebo group (38 [2·4%]; HR 3·64, 2·54-5·22).

Interpretation: In patients undergoing major non-cardiac thoracic surgery, administration of colchicine did not significantly reduce the incidence of clinically important atrial fibrillation or MINS but increased the risk of mostly benign non-infectious diarrhoea.

Funding: Canadian Institutes of Health Research, Accelerating Clinical Trials Consortium, Innovation Fund of the Alternative Funding Plan for the Academic Health Sciences Centres of Ontario, Population Health Research Institute, Hamilton Health Sciences, Division of Cardiology at McMaster University, Canada; Hanela Foundation, Switzerland; and General Research Fund, Research Grants Council, Hong Kong.

背景:较高水平的炎症生物标志物与非心脏手术后围手术期心房颤动和心肌损伤的风险增加有关。秋水仙碱是一种抗炎药,可以降低这些并发症的发生率。方法:COP-AF是一项随机试验,在11个国家的45个地点进行。年龄在55岁或55岁以上并接受大型非心脏胸部手术的患者被随机分配(1:1)接受口服秋水仙碱0.5 mg,每日两次或匹配的安慰剂,在手术前4小时内开始,持续10天。使用计算机化、基于网络的系统进行随机分组,并按中心进行分层。医疗服务提供者、患者、数据采集者和裁决者都被掩盖在治疗任务之外。在14天的随访中,共同主要结果是具有临床意义的围手术期心房颤动和MINS。主要的安全性结果是败血症或感染以及非感染性腹泻的复合。所有分析均采用意向治疗原则。该试验在ClinicalTrials.gov,NCT03310125上注册。研究结果:在2018年2月14日至2023年6月27日期间,我们招募了3209名患者(平均年龄68岁[SD7],1656[51.6%]男性)。1608名服用秋水仙碱的患者中有103名(6.4%)发生了临床上重要的心房颤动,1601名服用安慰剂的患者中也有120名(7.5%)发生了心房颤动(危险比[HR]0.85,95%CI 0.65-1.10;绝对风险降低[ARR]1.1%,95%CI-0.7-2.8;p=0.22)。在295名(18.3%)服用秋水仙碱的患者和325名(20.3%)服用安慰剂的患者中发生了MINS(HR0.89,0.76至1.05;ARR2.0%,-0.8至4.7;p=0.16)。秋水仙碱组103例(6.4%)患者和安慰剂组83例(5.2%)患者出现败血症或感染的综合转归(HR 1.24,0.93-1.66)。非感染性腹泻在秋水仙碱组(134例[8.3%])比安慰剂组(38例[2.4%];HR 3.64,2.54-5.22)更常见,秋水仙碱的给药并没有显著降低临床上重要的心房颤动或MINS的发生率,但增加了大多数良性非感染性腹泻的风险。资助:加拿大卫生研究院、加速临床试验联盟、安大略省学术健康科学中心替代资助计划创新基金、人口健康研究所、汉密尔顿健康科学、加拿大麦克马斯特大学心脏病学系;哈内拉基金会,瑞士;香港研究资助局普通研究基金。
{"title":"Effect of colchicine on perioperative atrial fibrillation and myocardial injury after non-cardiac surgery in patients undergoing major thoracic surgery (COP-AF): an international randomised trial.","authors":"David Conen, Michael Ke Wang, Ekaterine Popova, Matthew T V Chan, Giovanni Landoni, Juan P Cata, Cara Reimer, Sean R McLean, Sadeesh K Srinathan, Juan Carlos Trujillo Reyes, Ascension Martín Grande, Anna Gonzalez Tallada, Daniel I Sessler, Edith Fleischmann, Barbara Kabon, Luca Voltolini, Patrícia Cruz, Donna E Maziak, Laura Gutiérrez-Soriano, William F McIntyre, Vikas Tandon, Elisabeth Martínez-Téllez, Juan Jose Guerra-Londono, Deborah DuMerton, Randolph H L Wong, Anna L McGuire, Biniam Kidane, Diego Parise Roux, Yaron Shargall, Jennifer R Wells, Sandra N Ofori, Jessica Vincent, Lizhen Xu, Zhuoru Li, John W Eikelboom, Sanjit S Jolly, Jeff S Healey, P J Devereaux","doi":"10.1016/S0140-6736(23)01689-6","DOIUrl":"10.1016/S0140-6736(23)01689-6","url":null,"abstract":"<p><strong>Background: </strong>Higher levels of inflammatory biomarkers are associated with an increased risk of perioperative atrial fibrillation and myocardial injury after non-cardiac surgery (MINS). Colchicine is an anti-inflammatory drug that might reduce the incidence of these complications.</p><p><strong>Methods: </strong>COP-AF was a randomised trial conducted at 45 sites in 11 countries. Patients aged 55 years or older and undergoing major non-cardiac thoracic surgery were randomly assigned (1:1) to receive oral colchicine 0·5 mg twice daily or matching placebo, starting within 4 h before surgery and continuing for 10 days. Randomisation was done with use of a computerised, web-based system, and was stratified by centre. Health-care providers, patients, data collectors, and adjudicators were masked to treatment assignment. The coprimary outcomes were clinically important perioperative atrial fibrillation and MINS during 14 days of follow-up. The main safety outcomes were a composite of sepsis or infection, and non-infectious diarrhoea. The intention-to-treat principle was used for all analyses. This trial is registered with ClinicalTrials.gov, NCT03310125.</p><p><strong>Findings: </strong>Between Feb 14, 2018, and June 27, 2023, we enrolled 3209 patients (mean age 68 years [SD 7], 1656 [51·6%] male). Clinically important atrial fibrillation occurred in 103 (6·4%) of 1608 patients assigned to colchicine, and 120 (7·5%) of 1601 patients assigned to placebo (hazard ratio [HR] 0·85, 95% CI 0·65 to 1·10; absolute risk reduction [ARR] 1·1%, 95% CI -0·7 to 2·8; p=0·22). MINS occurred in 295 (18·3%) patients assigned to colchicine and 325 (20·3%) patients assigned to placebo (HR 0·89, 0·76 to 1·05; ARR 2·0%, -0·8 to 4·7; p=0·16). The composite outcome of sepsis or infection occurred in 103 (6·4%) patients in the colchicine group and 83 (5·2%) patients in the placebo group (HR 1·24, 0·93-1·66). Non-infectious diarrhoea was more common in the colchicine group (134 [8·3%] events) than the placebo group (38 [2·4%]; HR 3·64, 2·54-5·22).</p><p><strong>Interpretation: </strong>In patients undergoing major non-cardiac thoracic surgery, administration of colchicine did not significantly reduce the incidence of clinically important atrial fibrillation or MINS but increased the risk of mostly benign non-infectious diarrhoea.</p><p><strong>Funding: </strong>Canadian Institutes of Health Research, Accelerating Clinical Trials Consortium, Innovation Fund of the Alternative Funding Plan for the Academic Health Sciences Centres of Ontario, Population Health Research Institute, Hamilton Health Sciences, Division of Cardiology at McMaster University, Canada; Hanela Foundation, Switzerland; and General Research Fund, Research Grants Council, Hong Kong.</p>","PeriodicalId":18014,"journal":{"name":"The Lancet","volume":" ","pages":"1627-1635"},"PeriodicalIF":168.9,"publicationDate":"2023-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10166081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
The Lancet
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1